High levels of atazanavir and darunavir in urine and crystalluria in asymptomatic patients.
about
Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study.Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patientsAtazanavir nephrotoxicity.Relationships between Serum Levels of Atazanavir and Renal Toxicity or Lithiasis.Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study.Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.HIV medication-based urolithiasis.Renal effects of novel antiretroviral drugs.Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations.Human immunodeficiency virus (HIV)-related stone disease - a potential new paradigm?Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge.Effect of hepatitis B and C clearance on atazanavir exposure.Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.
P2860
Q34542154-9C8F8D6E-262D-43DE-8D45-1DE1BE7BE655Q35018821-D541E934-2D06-40FA-8998-6064ADB7131AQ35207867-07B29778-3B6B-44A7-B863-53A06242CD6FQ35630635-03EB92C9-F55C-48DF-A259-CE64BD4D6009Q37176009-57F77363-0FDB-4631-8EC9-DEE98CD5C4B1Q37613237-E6E70BB9-34E8-4E1B-9F9E-24BAF9FC6175Q38411142-5336AFFC-CA09-41E5-B7CE-98A81664924DQ38837077-AC9FA3C0-9239-46DA-9E57-621D1F908934Q39074109-9EE32364-1B96-4249-980B-26737E8E4DB4Q41688518-9F0510FB-27E0-4D66-8394-C8301E62B988Q49629769-186B36E5-5C26-423E-8151-0A09177DDD1AQ50729885-4F839542-369A-4A1E-8480-B66977C4E475Q50975705-778D0570-828D-40DA-B944-330FA12E8060Q54240869-39981E72-A8C6-4814-BFF0-A413550C62E6
P2860
High levels of atazanavir and darunavir in urine and crystalluria in asymptomatic patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
High levels of atazanavir and ...... uria in asymptomatic patients.
@en
High levels of atazanavir and ...... uria in asymptomatic patients.
@nl
type
label
High levels of atazanavir and ...... uria in asymptomatic patients.
@en
High levels of atazanavir and ...... uria in asymptomatic patients.
@nl
prefLabel
High levels of atazanavir and ...... uria in asymptomatic patients.
@en
High levels of atazanavir and ...... uria in asymptomatic patients.
@nl
P2093
P2860
P356
P1476
High levels of atazanavir and ...... uria in asymptomatic patients.
@en
P2093
Benedicte Loze
Erika Ferrari Rafael De Silva
Hélène Sauvageon
Jean-Michel Molina
Michel Daudon
Victoire de Lastours
P2860
P304
P356
10.1093/JAC/DKT125
P407
P577
2013-04-18T00:00:00Z